Resmed Inc Stock Buy Hold or Sell Recommendation
| RMD Stock | USD 249.33 0.66 0.26% |
Considering the 90-day investment horizon and your conservative risk appetite, our recommendation regarding ResMed Inc is 'Sell'. Macroaxis provides ResMed buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ResMed positions.
Check out ResMed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as ResMed and provide practical buy, sell, or hold advice based on investors' constraints. ResMed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
ResMed |
Execute ResMed Buy or Sell Advice
The ResMed recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on ResMed Inc. Macroaxis does not own or have any residual interests in ResMed Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ResMed's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
ResMed Trading Alerts and Improvement Suggestions
| ResMed Inc has a strong financial position based on the latest SEC filings | |
| About 61.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Peter Farrell of 1468 shares of ResMed at 249.56 subject to Rule 16b-3 |
ResMed Returns Distribution Density
The distribution of ResMed's historical returns is an attempt to chart the uncertainty of ResMed's future price movements. The chart of the probability distribution of ResMed daily returns describes the distribution of returns around its average expected value. We use ResMed Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of ResMed returns is essential to provide solid investment advice for ResMed.
| Mean Return | 0.06 | Value At Risk | -2.59 | Potential Upside | 2.08 | Standard Deviation | 1.68 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of ResMed historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
ResMed Stock Institutional Investors
| Shares | Charles Schwab Investment Management Inc | 2024-09-30 | 924 K | Fidelity International Ltd | 2024-06-30 | 780.7 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 742.4 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 676.4 K | Congress Asset Management Company, Llp | 2024-09-30 | 567.5 K | Lgt Capital Partners Ltd. | 2024-06-30 | 564 K | Jpmorgan Chase & Co | 2024-06-30 | 538.2 K | Tandem Investment Advisors Inc | 2024-09-30 | 496.7 K | Coatue Management Llc | 2024-09-30 | 473.2 K | Vanguard Group Inc | 2024-09-30 | 18 M | Blackrock Inc | 2024-06-30 | 11.7 M |
ResMed Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (69.9M) | (22.0M) | (311.7M) | (248.8M) | 172.2M | 180.8M | |
| Change In Cash | 316.0M | (167.9M) | (21.6M) | (45.8M) | 10.5M | 6.5M | |
| Free Cash Flow | 696.3M | 619.9M | 195.1M | 559.3M | 1.3B | 1.4B | |
| Depreciation | 181.4M | 191.5M | 193.8M | 197.6M | 216.2M | 227.0M | |
| Other Non Cash Items | (7K) | 8.7M | 20.7M | (11.1M) | 39.1M | 41.1M | |
| Capital Expenditures | 105.9M | 116.8M | 156.0M | 134M | 114.9M | 66.9M | |
| Net Income | 621.7M | 474.5M | 779.4M | 897.6M | 1.0B | 1.1B | |
| End Period Cash Flow | 463.2M | 295.3M | 273.7M | 227.9M | 238.4M | 334.2M | |
| Dividends Paid | 225.1M | 226.7M | 245.3M | 258.3M | 282.3M | 203.0M | |
| Change To Netincome | 82.6M | 69.3M | 85.9M | 60.3M | 69.4M | 45.6M | |
| Investments | (46.0M) | (158.5M) | (13.9M) | (1.2B) | (269.8M) | (256.3M) | |
| Net Borrowings | (94.0M) | (522M) | 122M | 665M | 764.8M | 803.0M |
ResMed Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ResMed or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ResMed's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ResMed stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | 0.26 | |
σ | Overall volatility | 1.72 | |
Ir | Information ratio | -0.04 |
ResMed Volatility Alert
ResMed Inc has relatively low volatility with skewness of 0.2 and kurtosis of 5.68. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ResMed's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ResMed's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.ResMed Fundamentals Vs Peers
Comparing ResMed's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ResMed's direct or indirect competition across all of the common fundamentals between ResMed and the related equities. This way, we can detect undervalued stocks with similar characteristics as ResMed or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ResMed's fundamental indicators could also be used in its relative valuation, which is a method of valuing ResMed by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ResMed to competition |
| Fundamentals | ResMed | Peer Average |
| Return On Equity | 0.24 | -0.31 |
| Return On Asset | 0.13 | -0.14 |
| Profit Margin | 0.23 % | (1.27) % |
| Operating Margin | 0.32 % | (5.51) % |
| Current Valuation | 37.02 B | 16.62 B |
| Shares Outstanding | 146.8 M | 571.82 M |
| Shares Owned By Insiders | 0.77 % | 10.09 % |
| Shares Owned By Institutions | 61.32 % | 39.21 % |
| Number Of Shares Shorted | 7.31 M | 4.71 M |
| Price To Earning | 73.48 X | 28.72 X |
| Price To Book | 7.05 X | 9.51 X |
| Price To Sales | 7.61 X | 11.42 X |
| Revenue | 4.69 B | 9.43 B |
| Gross Profit | 2.39 B | 27.38 B |
| EBITDA | 1.53 B | 3.9 B |
| Net Income | 1.02 B | 570.98 M |
| Cash And Equivalents | 273.71 M | 2.7 B |
| Cash Per Share | 1.87 X | 5.01 X |
| Total Debt | 873.93 M | 5.32 B |
| Debt To Equity | 0.27 % | 48.70 % |
| Current Ratio | 2.80 X | 2.16 X |
| Book Value Per Share | 35.39 X | 1.93 K |
| Cash Flow From Operations | 1.4 B | 971.22 M |
| Short Ratio | 6.31 X | 4.00 X |
| Earnings Per Share | 7.53 X | 3.12 X |
| Price To Earnings To Growth | 1.89 X | 4.89 X |
| Target Price | 253.39 | |
| Beta | 0.69 | -0.15 |
| Market Capitalization | 36.6 B | 19.03 B |
| Total Asset | 6.87 B | 29.47 B |
| Retained Earnings | 4.99 B | 9.33 B |
| Working Capital | 1.45 B | 1.48 B |
| Current Asset | 1.42 B | 9.34 B |
Note: Disposition of 2000 shares by Michael Farrell of ResMed at 249.665 subject to Rule 16b-3 [view details]
ResMed Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ResMed . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About ResMed Buy or Sell Advice
When is the right time to buy or sell ResMed Inc? Buying financial instruments such as ResMed Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having ResMed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Moderate Funds Thematic Idea Now
Moderate Funds
Funds or Etfs that combine stocks, bonds and money market instruments to get modest capital appreciation over time. The Moderate Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Moderate Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out ResMed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.416 | Dividend Share 1.97 | Earnings Share 7.53 | Revenue Per Share 32.711 | Quarterly Revenue Growth 0.111 |
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.